000 01308 a2200397 4500
005 20250513021335.0
264 0 _c19820527
008 198205s 0 0 eng d
022 _a0378-7966
024 7 _a10.1007/BF03189521
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aForsman, A
245 0 0 _aOn the distribution and elimination of haloperidol in cholecystectomized patients.
_h[electronic resource]
260 _bEuropean journal of drug metabolism and pharmacokinetics
_c1981
300 _a249-53 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdipose Tissue
_xmetabolism
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aBile
_xmetabolism
650 0 4 _aCholecystectomy
650 0 4 _aCholelithiasis
_xmetabolism
650 0 4 _aEnterohepatic Circulation
650 0 4 _aFemale
650 0 4 _aHaloperidol
_xmetabolism
650 0 4 _aHumans
650 0 4 _aKinetics
650 0 4 _aLiver
_xmetabolism
650 0 4 _aMale
650 0 4 _aMiddle Aged
700 1 _aLarsson, M
700 1 _aLundborg, H
700 1 _aRenstrom, P
773 0 _tEuropean journal of drug metabolism and pharmacokinetics
_gvol. 6
_gno. 4
_gp. 249-53
856 4 0 _uhttps://doi.org/10.1007/BF03189521
_zAvailable from publisher's website
999 _c7332836
_d7332836